Concepedia

Publication | Open Access

A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A

50

Citations

61

References

2020

Year

Abstract

A novel HDAC6 inhibitor, CKD-504, has potent therapeutic efficacy for CMT1A.

References

YearCitations

Page 1